The global pharmaceutical gelatin market is anticipated to reach USD 2.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2022 to 2032. Among global regions, Asia Pacific is expected to witness the fastest growth, driven by rising pharmaceutical production, increasing healthcare expenditure, and growing demand for gelatin-based drug delivery systems. The expanding pharmaceutical and nutraceutical industries in countries like China and India further boost the demand for pharmaceutical gelatin in this region.
Pharmaceutical gelatin is primarily derived from collagen found in animal body parts such as bones and skin. It is a translucent, flavorless, and naturally pleasant substance widely used in the pharmaceutical industry. When dry, gelatin is fragile, but it becomes elastic and springy upon contact with moisture, making it an ideal material for manufacturing capsules. Its unique physical and chemical properties allow it to protect active pharmaceutical ingredients while facilitating controlled drug release in the body.
Hard gelatin capsules are produced by dipping molds into a warm gelatin solution, followed by drying and trimming to form cap and body parts. These capsules are then filled with dry powdered drugs or supplements and sealed for distribution. Hard gelatin capsules are favored for their convenience, ease of swallowing, and ability to mask unpleasant tastes or odors of medications. Pharmaceutical companies extensively use these capsules to deliver precise dosages efficiently.
Grab The Sample Report ➣ https://www.thebrainyinsights.com/enquiry/sample-request/13298
Soft gelatin capsules, on the other hand, are produced by molding two gelatin sheets into a specific shape and size simultaneously while filling them with liquid or semi-liquid drug formulations. The soft gelatin capsule manufacturing process allows the encapsulation of oils, suspensions, and other liquid ingredients, enhancing drug bioavailability and stability. Soft gelatin capsules also aid in masking the unpleasant taste and odor of certain drugs, making them more patient-friendly.
Besides capsules, pharmaceutical gelatin is also used in producing suppositories, where it acts as a binding agent and helps in the gradual release of medications. Gelatin’s ability to break down specifically in the digestive tract enhances the controlled release of active ingredients, making it valuable for various drug delivery methods. Its biocompatibility and safety profile contribute to its widespread acceptance in the pharmaceutical sector.
In summary, the pharmaceutical gelatin market is growing steadily due to increasing demand for efficient drug delivery systems and expanding pharmaceutical manufacturing. Innovations in capsule technology, along with the rising preference for nutraceuticals and supplements, are further propelling the market. The Asia Pacific region’s rapid industrialization and growing healthcare infrastructure are expected to provide significant opportunities for market expansion during the forecast period.
Other Related Reports:
Top comments (0)